Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 3 Insider Initial Statement of Ownership
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. EFFECT Other Notice of Effectiveness
  7. 8-K Event Executive or director change
  8. POS AM Other Post-effective Amendment for Registration Statement
  9. 4 Planned sale EVP, CHIEF FINANCIAL OFFICER sold 4,109 shares at $1.71 ($7,030)
  10. 4 Planned sale CEO sold 16,632 shares at $1.71 ($28,452)
  11. 4 Planned sale EVP, CHIEF SCIENTIFIC OFFICER sold 2,891 shares at $1.71 ($4,946)
  12. S-8 Other Securities Offered to Employees in Benefit Plans
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. POSASR Other POSASR
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 8-K Event Results of operations · Regulation FD disclosure

Page 6 of 37 · 731 filings